DoxyPEP — a single dose of doxycycline after sex to cut your risk of bacterial STIs (syphilis, chlamydia, and to a lesser degree gonorrhoea) — has no official guideline in Japan. No national recommendation either way. In practice it lives in a grey zone: some private sexual-health clinics in Tokyo will prescribe it off-label, Japanese researchers have studied it, and it's entirely self-pay. For what it does and doesn't prevent, use the general doxyPEP guide linked below. This page is about getting it here.

📋 The Local Position

  • Guideline status: None. No health-authority recommendation, so this is off-label — a call between you and a willing doctor.
  • Who offers it: A small number of private sexual-health clinics, mostly in Tokyo. The Personal Health Clinic (Tokyo) has published research on doxycycline prophylaxis, so clinics like it are your realistic starting point.
  • Cost: Self-pay. The doxycycline itself is cheap; you pay the private consultation on top.

🗣️ How to Ask

There's no standard programme, so you raise it yourself at a clinic that already handles PrEP and gay men's sexual health. Ask whether they'll provide doxycycline post-exposure prophylaxis (ドキシサイクリンによる予防投与) and on what terms. A clinic running PrEP is far more likely to engage than a general practice.

Don't build a doxyPEP habit on leftover or imported antibiotics with no clinical input. DoxyPEP does little against resistant gonorrhoea and is no substitute for regular three-site testing. Use it inside a monitored plan, not instead of one. Sourcing your own doxycycline? Still get three-site swab testing on your normal schedule — the hokenjo guide below covers where.

⚖️ Weighing It Up

  • Strong for syphilis and chlamydia: meaningfully cuts both in men who have sex with men.
  • Cheap drug: doxycycline is low-cost and widely available.
  • On-demand: taken only after sex, not daily.
  • No local guideline: you're relying on one doctor's willingness to prescribe off-label.
  • Weak on gonorrhoea: resistance limits the benefit there.
  • Resistance concerns: the reason no blanket recommendation exists yet.

Related: